Clinical-pharmacological aspects of perindopril in the treatment of chronic pulmonary heart disease The study included 46 patients with COPD complicated with CPH, treated with ACE inhibitor - perindopril associated with basic therapy. It was found that the inclusion of perindopril in the complex treatment of patients with COPD complicated by CPH improves the clinical course of disease, beneficially acting on indices of central and intracardiac hemodynamics and on cardiac arrhythmias.

Studiul a inclus 46 pacienţi cu BPCO complicată cu CPC, cărora li s-a efectuat tratamentul cu inhibitorul ECA – perindopril asociat cu terapia de bază. S-a constatat că includerea perindoprilului în tratamentul complex al pacienţilor cu BPCO complicat cu CPC ameliorează evoluţia clinică a maladiei, acţionează benefic asupra indicilor hemodinamicii centrale şi intracardiace, şi asupra tulburărilor de ritm cardiac.